Press enter to see results or esc to cancel.

Brand new Alzheimer’s Treatment Shows True Promise in Slowing Cognition Decline Using Antibody in Human Trials

The major pharmaceutical firm Eli Lilly has just proven efficacy of their Alzheimer’ t drug donanemab in phase 2 clinical human trials. The results are a major advancement for the treatment of a disease that currently affects six mil Americans, but that has very little methods of alleviation. Alzheimer’ h is caused by the accumulation of tau […]

The particular post New Alzheimer’s Therapy Shows Real Promise in Slowing Cognition Decline Using Antibody in Human Tests appeared first on Great news Network.